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Abstract
Schizophrenia has long been characterized solely by positive and negative symptoms of
psychosis. It has also been typified by its widespread heterogeneity, which has impeded
treatment outcomes. Previous attempts at reducing this heterogeneity via identifying
symptom-based subtypes has been unhelpful and unreliable. More recently, cognitive
deficits have been identified as prominent features of the disorder and are now included
as necessary diagnostic criteria. The present study aimed to identify the unique
relationships between cognitive deficits and psychotic symptoms and to establish
subtypes based on these profiles. The findings suggest two distinct subtypes: (a) a deficit
subtype wherein individuals display more severe psychotic symptoms and more severe
cognitive deficits overall, and (a) a nondeficit subtype wherein individuals have less
severe psychotic symptoms, as well as less severe cognitive deficits overall. These
subtypes also differed on the following variables of interest: race, employment,
education, and history of antipsychotic medication. Specifically, the Deficit subtype was
composed of more Black participants than White, had fewer years of education, and had a
longer duration since first prescribed antipsychotic medication. The Nondeficit subtype,
conversely, was composed of more White participants, a longer work history, more
education, and fewer years since first prescribed antipsychotic medication. These findings
have potential implications for the efficacy of diagnosis, treatment, and prevention
strategies.
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IDENTIFYING SUBTYPES OF SCHIZOPHRENIA
Chapter 1: Introduction
Statement of the Problem
Schizophrenia is among the most severe forms of mental illness (Arieti, 1974).
Positive and negative symptoms are prominent features of this disorder and have thus
become central targets for treatment (Geddes, Freemantle, Harrison, & Bebbington,
2000). Positive symptoms include auditory and visual hallucinations, delusions,
suspiciousness, hostility, and conceptual disorganization, while negative symptoms
include blunted affect, emotional withdrawal, apathy, stereotyped thinking, and poor
rapport with others (Kay, Flszbein, & Opfer, 1987). More recently, cognitive deficits have
garnered attention as viable indicators of both positive and negative symptom severity
and have warranted further study based on their resistance to traditional treatment
methods and high correlation with functional outcomes (Gold, 2004). Namely, severe
cognitive deficits tend to persist despite positive and negative symptom abatement and
therefore inhibit treatment success as a result of their hindrance on one’s ability to carry
out activities of daily living (Gold, 2004). This finding suggests the unidirectional
relationship between cognitive deficits and positive and negative symptoms in that
severity of cognitive deficit is a marker of positive and negative symptom severity,
though the same is not necessarily true in the reverse (Arieti, 1974).
Since its inception, schizophrenia has been thought of as a multidimensional
construct (Carpenter, Bartko, Carpenter, & Strauss, 1976). The term schizophrenia was
originally used to denote a group of mental illnesses that were comprised of any
combination of positive and negative symptoms of psychosis (Carpenter et al., 1976).
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The widespread heterogeneity inherent in schizophrenia has been observed and
documented since antiquity, eventually inciting the use of subtypes meant to categorize
these differences (Fenton & McGlashan, 1991). Historically, a symptom-focused
approach to differentiating subtypes dominated clinical manuals (Fenton & McGlashan,
1991). Some of these subtypes include paranoid, disorganized, catatonic,
undifferentiated, and residual and were based solely on an individual’s most prominent
symptoms (Hoenig, 1983).
The most recent edition of the Diagnostic and Statistical Manual of Mental
Disorders (5th ed.; DSM–5; American Psychiatric Association, 2013) has eliminated
these subtypes because of their lack of reliability and clinical utility. Namely, a symptomfocused approach to diagnostic delineation is unreliable because of the transient nature of
the symptoms and tendency for symptom overlap (Fenton & McGlashan, 1991).
Moreover, positive and negative symptom fluctuation hinders the ability to measure and
thus accurately diagnose subtypes within schizophrenia (Carpenter et al., 1976).
Despite these challenges, identifying subtypes remains an important endeavor.
Previous researchers have successfully demonstrated that identifying phenotypic subtypes
of heterogeneous disorders has improved diagnostic accuracy, expounded upon genetic
etiology, and bettered treatment outcomes for autism spectrum disorder (Shao et al.,
2002), Parkinson’s disease (Dekker et al., 2003), and Alzheimer’s disease (Scott et al.,
2003). These findings suggest that this same type of refinement may be applied to
schizophrenia to yield similar advances in conceptual, diagnostic, and treatment domains.
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In response to a failed symptom-focused approach to identifying effective and
accurate subtypes, researchers and clinicians have considered the utility of cognitive
deficits as markers of subtypes within schizophrenia instead (Fioravanti, Carlone, Vitale,
Cinti, & Clare, 2005). Refocusing on cognitive deficits as a method of differentiation
emerged as a result of increasing support for their correlation with distinct positive and
negative symptoms (Elvevag & Goldberg, 2000). Furthermore, cognitive deficits are
easily measured and observed and tend to be enduring features of schizophrenia (Hoenig,
1983). Thus, cognitive deficits can provide information about symptom patterns and
severity while being less susceptible to some of the limitations set forth by a symptomfocused paradigm (Elvevag & Goldberg, 2000).
Although cognitive deficits are at present acknowledged as longstanding and
central features of schizophrenia, researchers have disagreed on whether cognitive
deficits are generalized or domain specific (Lencz et al., 2006). While some argue that
individuals with schizophrenia have deficits across all cognitive domains, others argue
that the deficits are specific to certain functions and based on particular symptom
presentations (Dickinson, Ragland, Gold, & Gur, 2008). With increasing consistency,
researchers have demonstrated that negative symptoms are correlated with frontal
functional deficits, while positive symptoms are associated with auditory deficits and
more widespread neural networks that underlie attention (O’Leary et al., 2000). Based on
these emerging patterns of positive and negative symptoms, generalized deficits clearly
do not account for the full range of symptom presentations observed in clinical practice.
These differential impairments support the domain-specific theory of cognitive deficits in
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schizophrenia and further suggest the existence of subtypes within schizophrenia that can
be classified based on these cognitive deficits.
Neuropsychological tests have been used extensively with this population to
further investigate the notion of generalized versus specific cognitive deficits in
schizophrenia. Studies that support the generalized-deficit theory, however, have
demonstrated controversial methodologies, small sample sizes, and various other
shortcomings that belie the veracity of their results (Fioravanti et al., 2005). Researchers
have acknowledged that a domain-specific approach to understanding neurocognitive
deficits would lend itself more easily to profiling individuals with schizophrenia (Gray,
McMahon, & Gold, 2013). This notion parallels the emergence of domain-specific
cognitive deficits that are correlated with specific positive and negative symptoms (Gold,
2004). These correlations between psychotic symptoms and specific cognitive deficits
further implicate the existence of subtypes within schizophrenia.
Furthermore, studies that investigate specific versus generalized cognitive deficits
have been ill equipped to address the question of targeted neurocognitive profiles in
relation to symptom presentation, as they have investigated these constructs only in
isolation (Gray, McMahon, & Gold, 2013). Distinguishing subtypes within schizophrenia
based on differential neurocognitive profiles is essentially a novel approach to exploring
the widespread variability of cognitive deficits observed in this disorder. Effective
treatment is contingent upon an accurate understanding of the illness, which requires
specification through subtypes to decrease the widespread heterogeneity of symptom
presentations (O’Leary et al., 2000).
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Interventions, nonetheless, have aimed at only positive and negative symptom
reduction and have had limited success with the latter (Dickinson et al., 2008). The
treatment for schizophrenia is essentially a generalized regimen, regardless of variations
in symptom presentation, and is often ineffective for individuals who deviate from the
typical symptom profile (Arieti, 1974). The reason for this generalized treatment
approach is trifold: (a) Clinicians lack a clear understanding of the nature of
neurocognitive deficits and their correlation with symptom presentations, (b) positive
symptoms have been erroneously correlated with functional outcomes and therefore
given precedence over other features of the illness, and (c) subtypes of schizophrenia
based on neurocognitive profiles and associated symptom presentations have yet to be
identified (Gold, 2004). As such, identifying subtypes of schizophrenia using a domainspecific neurocognitive approach may help to target and improve treatment, with
particular emphasis on fostering clinical, genetic, and pharmacological studies (Velligan,
Bow-Thomas, Mahurin, Miller, & Halgunseth, 2000). Moreover, accuracy in diagnostic
delineation has the potential to improve not only treatment strategies and functional
outcomes, but also prevention and research (Velligan et al., 2000).
Purpose of the Study
The purpose of the present study was to stimulate the delineation of subtypes of
schizophrenia through identifying patterns of cognitive deficits as they relate to patterns
of symptoms in schizophrenia. Identifying these patterns of cognitive deficits and related
symptoms was achieved through an examination of domain-specific cognitive deficits
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and their correlations with positive and negative symptoms among individuals suffering
from schizophrenia.
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Chapter 2: Review of the Literature
Background and Overview
Schizophrenia, as it is now conceptualized, is a relatively new diagnostic entity.
The term itself is fewer than 100 years old and was coined by Swiss psychiatrist Paul
Eugene Bleuler in 1910 (Ciompi, 1980). The word is derived from the Greek words
schizo, meaning split, and phren, meaning mind (Johnstone et al., 1978). Thus,
historically, schizophrenia was characterized predominantly by the division or loosening
of cognitions that are apparent in the disorder. Despite variations in name, the incidence
of schizophrenia has been well documented since antiquity. Dementia Praecox, which
means dementia of early life, was the original term used to classify the disorder (Bleuler,
1950). Dementia Praecox was conceived by German psychiatrist Emil Kraepelin and was
based on the overt cognitive deficits that characterized his patients (Johnstone et al.,
1978).
More generally, the term psychosis was used to typify individuals who would
meet present-day criteria for schizophrenia. Psychosis was originally an abbreviation for
psychic neurosis, which essentially referred to a symptom of brain disease (Aderibigbe,
Theodoridis, & Vieweg, 1999). Brain disease was the hypothesized cause of
schizophrenia-like symptoms, with particular emphasis given to cognitive decline and
general impairments in cognitive processes, such as memory, speech, ideations, and
problem solving (Bleuler, 1950). Despite an overt historical emphasis on cognitive
deficits as its hallmark, the focal point of schizophrenia shifted once clinicians looked to
treat, rather than to define, the disorder.
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At present, the term psychosis is a prominent feature of schizophrenia and is
primarily compossed of positive and negative symptoms (Aderibigbe et al., 1999).
Positive symptoms refer to delusions, hallucinations, and thought disorganization,
whereas negative symptoms refer to blunted affect and avolition (Liddle, 1987). Only
more recently have cognitive deficits attained recognition as mainstays of schizophrenia
and psychosis in general, despite being historically regarded as the apex of the disorder
(Lewis & Lieberman, 2000). This re-focus on cognitive deficits is likely owing to the
covert nature of cognitive deficits, rather than to the more overt portrayal of positive and
negative symptoms in schizophrenia (Gold & Harvey, 1993). Cognitive deficits in
schizophrenia refer to problems with attention, memory, verbal fluency, verbal learning,
and executive functioning (Gold, 2004; Gold & Harvey, 1993; Mohamed, Paulsen,
O’Leary, Arndt, & Andreasen, 1999).
Currently, the DSM–5 requires two or more of the following symptoms to warrant
a diagnosis of schizophrenia: delusions, hallucinations, disorganized speech, grossly
disorganized or catatonic behavior, and negative symptoms (American Psychiatric
Association, 2013). The presence or absence of symptoms presented by any given patient
varies considerably. Following the onset of psychosis, patients may exhibit
predominantly negative symptoms, predominantly positive symptoms, or both (Carpenter
Jr., & Kirkpatrick, 1988). Thus, the potential for widespread variability among
individuals diagnosed with schizophrenia is evidenced by the magnitude of potential
symptom combinations (Carpenter Jr., & Kirkpatrick, 1988).

IDENTIFYING SUBTYPES OF SCHIZOPHRENIA

9

Owing to this variability, schizophrenia has been deemed pathophysiologically
heterogeneous, thus posing several obstacles to the conceptualization, course, and
treatment of the disorder (Arango, Kirkpatrick, & Buchanan, 2000). A number of studies
have employed factor analyses to reduce heterogeneity via the establishment of
homogenous subtypes. Despite minor differences, these studies have fairly consistently
demonstrated the emergence of at least three subtypes of schizophrenia: hallucinations
and delusions, disorganization of thought and behavior, and negative symptoms, all of
which were included in subsequent editions of diagnostic manuals (Arango et al., 2000;
Brazo et al., 2002; Gilbert et al., 2014).
Previous editions of the DSM, for example, have included these three subtypes.
The most recent edition, however, has eliminated them based on symptom fluidity and
poor clinical utility (Keefe & Fenton, 2007). Namely, these subtypes have been based on
the symptoms of schizophrenia, which are transient and thus unreliable indicators of
group membership (Addington, Addington, & Maticka-Tyndale, 1991; Gilbert et al.,
2014). Researchers have instead looked to cognitive deficits to understand the
pathophysiology of positive and negative symptoms through an examination of the
relationship of positive and negative symptoms to particular cognitive domains (Strauss,
1993). In contrast to positive and negative symptoms, cognitive deficits are stable
features of schizophrenia and more likely to produce consistent and reliable information
upon further investigation (Che et al., 2012).
Identifying subtypes through phenotypic refinement has been successfully applied
in other psychiatric disorders. For example, researchers studying autism spectrum
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disorder (ASD) employed a factor analysis to identify homogenous subtypes based on
repetitive, stereotyped behaviors that are common in ASD (Shao et al., 2002). The results
of the analysis narrowed the chromosomal focus for the complex traits of the disorder. As
a result, the authors suggested that phenotypic subtypes can allow for mapping of disease
susceptibility genes, or risk factors, that can therefore have implications for prevention as
well (Shao et al., 2002).
Other studies have had similar success with complex disorders, such as
Parkinson’s disease and Alzheimer’s disease. Parkinson’s disease varies in presentation
and onset (Dekker et al., 2003). A study that aimed to identify homogenous subtypes of
the disorder found etiological differences between groups, which have had immediate
implications on genetic counseling, treatment approaches, and risk prediction (Dekker et
al., 2003). Alzheimer’s disease is an equally complex and heterogeneous disorder. The
use of subtypes in Alzheimer’s disease has yielded homogenous groups based on age at
onset (Scott et al., 2003) Specifically, three groups were identified: early onset, late onset,
and very late onset (Scott et al., 2003) Genetic differences among groups have verified
these subtypes, and they have allowed for a more thorough etiological understanding of
the disease. Moreover, identifying these subtypes has expanded the conceptualization of
Alzheimer’s disease beyond familial forms of the disease to include the sporadic forms of
it as well, meaning that identifying subtypes of a heterogeneous disease has advanced the
understanding of its pathophysiology, as well as increased diagnostic acuity (Scott et al.,
2003).
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Although recent advances have expounded the pathophysiology of schizophrenia,
the extreme variability in cognitive and clinical symptoms hinders a more thorough
understanding of the disorder, as well as impedes accurate diagnosis and efficient
treatment options. Thus, as has been successfully demonstrated with other disorders,
identifying subtypes based on homogenous groups within schizophrenia may likely
benefit each of these aims.
Cognitive Deficits
There is little doubt regarding the existence of cognitive deficits in schizophrenia.
Cognitive deficits are well-replicated, stable identifiers of the disorder (Gold, 2004). Two
theories compete, however, on the nature of cognitive deficits in schizophrenia. The first
theory postulates that cognitive deficits in schizophrenia are broad, generalized, and
undifferentiated (Dickinson & Harvey, 2009). The second theory states that cognitive
deficits in schizophrenia are domain specific and focal to particular symptoms of the
disorder (Schatz, 1998). Each of these theories has garnered a substantial amount of
attention in schizophrenia research in recent years. The generalized-deficit theory is not
amenable to identifying subtypes through differential neurocognitive profiles because its
main principle states that cognitive deficits in schizophrenia are broad and homologous.
Thus, to support the use of cognitive deficits as markers of subtypes in schizophrenia, the
general-deficit theory must be examined and deemed unfounded.
General Cognitive Deficits
Cognitive deficits in schizophrenia typically predate disease onset and remain
stable over time (Fioravanti et al., 2005). A body of literature supports a generalized-
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deficit approach to understanding cognition in schizophrenia. The generalized-deficit
approach refers to studies that have identified a commonality across all cognitive
domains, referred to as “g” (Dickinson et al., 2008). Specifically, researchers have
demonstrated that cognitive deficits in schizophrenia are mediated by a common ability
factor, which is illustrated by widespread deficits in neuropsychological performance
across all cognitive domains (Mohammed et al., 1999). Researchers further postulate that
this mediation is a result of high correlations between schizophrenia-related cognitive
deficits (Gold & Harvey, 1993). A sample of studies have attempted to support the notion
of undifferentiated cognitive impairment through analyzing neuropsychological profiles
of individuals with schizophrenia. One of these studies has implicated as much as 63% of
all diagnosis-related variance in cognitive performance as being accounted for by this
general ability factor alone (Dickinson et al., 2008).
Similarly, studies that have compared individuals with schizophrenia to healthy
subjects have determined that those with schizophrenia display significant cognitive
impairments across all cognitive domains, thus supporting the generalized-deficit theory
(Dickinson, Iannone, Wilk, & Gold., 2004; Dickinson et al., 2008; Mohammed et al.,
1999). Nonetheless, these very studies have simultaneously illustrated some domainspecific variance for verbal memory and processing speed, indicating that at least two
domains are specific to schizophrenia and differentiated from a general ability factor
(Cohen, Forbes, Mann, & Blanchard, 2006; Elvevag et al., 2000). These findings, among
others, led to the scrutiny of research that supported the generalized-deficit theory.
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In response, lead researchers in favor of the generalized-deficit theory worked to
minimize methodological flaws. For example, in an attempt to avoid potential confounds
inherent in medication effects, researchers began studying first-episode patients to amass
support for the generalized-deficit theory (Heydebrand et al., 2004). These studies have
also demonstrated diffuse cognitive deficits across all domains (Fioravanti et al., 2005).
Despite seemingly generalized impairments, however, more pronounced impairments
were evident in the results as well, specifically in verbal learning, memory, attention, and
processing speed (Gold, 2004). More recently, a study concluded similar findings in that
individuals with schizophrenia demonstrated generalized deficits across all functions,
with the exception of motor skills and verbal memory (Franck et al., 2001). Thus, across
all studies in support of the generalized-deficit theory, differential impairments in verbal
memory are a consistent exception (Fioravanti et al., 2005; Franck et al., 2001; Gold,
2004; Mohammed et al., 1999).
In addition to the emergence of domain-specific deficits in the literature, studies
that attempt to support the generalized-deficit theory have further methodological
limitations, including small sample sizes, insufficient within-group experimentation, and
poor reliability (Gold, 2004). Moreover, the vast majority of these studies likely reflect a
sampling bias, as they have examined almost exclusively chronically ill patients (Bryson,
Bell, & Lysaker, 1997). In doing so, these studies have not accounted for potential
confounds that are attributable to institutionalization or long-term medication effects that
can worsen cognitive deficits (; Bryson et al., 1997; Gold, 2004). The broad variability in
kind and magnitude of impairment necessitates a more thorough understanding of
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cognitive deficits in schizophrenia via a domain-focused approach. Identifying
independent dimensions of cognitive deficits would thus allow for the development and
implementation of effective interventions for differential impairments (Gold, 2004).
Overall, relevant literature suggests that the type and severity of cognitive deficits
vary widely by patient, in much the same way that particular positive and negative
symptoms vary by patient (O’Leary et al., 2000). Individuals with schizophrenia perform
worse than healthy subjects on neuropsychological assessments across all domains,
despite having within-group domain specificity (Gold & Harvey, 1993). Both withingroup analyses and analyses that compare individuals with schizophrenia to healthy
controls often fail to detect domain-specific deficits as a result of this widespread
variation. Conversely, studies that have compared the deficit subtype of schizophrenia
(i.e., those high on negative symptoms and low on positive symptoms) to the nondeficit
subtype have been able to identify domain-specific deficits, such as differential
impairments in cognitive flexibility, by analyzing more homogenous groups (Rethelyi,
Benkovits, & Bitter, 2012). Consequently, domain-specific deficits likely are masked by
the clinical heterogeneity of schizophrenia, but are nonetheless present. Moreover, the
presence of domain-specific deficits increases the plausibility of utilizing differential
neurocognitive profiles to identify subtypes of schizophrenia.
Domain-Specific Cognitive Deficits
The existence of differential domains in cognition is undisputed, and the reliable
measurement of these domains via neuropsychological assessments is equally
uncontested (Nuechterlein et al., 2008). Moreover, neuropsychological assessments were
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developed to capture and measure different cognitive processes, such as memory,
attention, and problem solving (Hartlage & DeFilippis, 1983). Namely,
neuropsychological assessments are already categorized into various domains that
purport to measure distinct neurological substrates. The domain-specific theory, then,
suggests differential impairment among these cognitive domains, in opposition to the
generalized-deficit theory, which acknowledges these domains but suggests they are
equally impaired (Gold, 2004).
The majority of the literature suggests that attention, working memory, processing
speed, verbal learning, and executive functioning are characteristically impaired in
schizophrenia (Strauss, 1993). In a recent study, authors explored whether cluster analysis
of these cognitive domains would define separate subtypes of schizophrenia (Gilbert et
al., 2014). The analysis yielded three clusters: one who performed in the near-normal
range of cognitive functioning; one with severe, general impairments across all cognitive
domains; and one with severe, selected cognitive impairments in the visual episodic
memory and processing-speed domains (Gilbert et al., 2014). A major limitation of this
study that likely accounts for the supposition of a generally impaired subtype rests in its
inclusion of only four cognitive domains, with three of them related to memory. These
domains include verbal memory, visual memory, working memory, and processing speed
(Gilbert et al., 2014). Thus, a more inclusive analysis likely would have identified
domain-specific deficits for this subtype as well. One also should note that the two
severely impaired clusters were nearly indistinguishable across measures of psychiatric
symptom severity (i.e., positive and negative symptoms of psychosis) at disease onset
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(Gilbert et al., 2014). This finding is consistent with the general literature that suggests
psychiatric symptoms alone are insufficient for distinguishing subtypes of schizophrenia.
Furthermore, this study identified relationships between clusters of cognitive
deficits and related functional outcomes (Gilbert et al., 2014). Functional outcomes are
defined in the literature as an individual’s ability to carry out activities of daily living,
including independent living (Bowie et al., 2008), social functioning (Addington &
Addington, 1999; Addington & Addington, 2000), and employment (Midin et al., 2011;
Sanchez et al., 2009). This study used the lifetime best estimate of response to treatment
(BER) assessment to measure functional outcomes. The BER provides a consensual
clinical judgement based on medical records, positive and negative syndrome scale
(PANSS) data, and a global assessment of functioning (GAF) score (Gilbert et al., 2014.
Individuals in the generalized-cognitive-deficit cluster were more likely to have treatment
refractory schizophrenia, whereas individuals with domain-specific cognitive deficits
demonstrated greater improvements on the BER (Gilbert et al., 2013). Overall, the
findings suggest that neurocognitive deficits are more central to functional outcomes than
are psychiatric symptoms of schizophrenia. These findings indicate that cognitive deficits
are imperative treatment targets in schizophrenia and could be better utilized in
intervention planning through the identification of subtypes.
To identify specific functional outcomes as they relate to specific cognitive
domains, a meta-analysis including 37 studies demonstrated moderate to strong effect
sizes on functional improvements, such as engaging in community and daily activities,
improvements in social problem solving, and psychosocial skill acquisition, for
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individuals in the executive-functioning, memory, and attention domains of cognition
(Green et al., 2000). This meta-analysis included studies that assessed generalized
impairment by calculating the global/composite measures of neurocognition. The results
demonstrated that between 20 and 60% of the variance in functional outcomes can be
explained by neurocognition (Green, Kern, Braff, & Mintz, 2000). Studies that used a
generalized-deficit approach, however, lacked the specificity required to determine which
domains should be targeted for interventions (Velligan, 2000). Thus, neurocognition in
schizophrenia is a crucial component to treatment success and requires a domain-specific
approach for generating effective interventions (Bowie et al., 2008) Despite some
variability, four cognitive domains are most commonly implicated in the literature as
being differentially impaired in schizophrenia: attention, memory, processing speed, and
executive functioning (Fioravanti et al., 2005). Given these deficits are unique to
schizophrenia, they may elucidate potential subtypes within this diagnostic category.
Deficits in attention, specifically, are considered to be the most fundamental in
individuals with schizophrenia and should be the first deficit cluster to examine (Carter et
al., 2010).
Attention. Attention, also referred to as vigilance, refers to one’s readiness to
differentially respond to a target stimulus and inhibit one’s response to a nontarget
(Saykin et al., 1991). Attentional deficits in schizophrenia are common and are often
universally apparent, despite variations in psychiatric symptom presentations (Mass,
Schoemig, Hitschfeld, Wall, & Haasen, 2000). Several studies have noted that deficits in
attention, like most cognitive deficits in schizophrenia, are detectable before the onset of
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the illness (Egeland et al., 2003). Attentional deficits in particular appear to predominate
in studies of early schizophrenia, with some researchers illustrating childhood attentional
deficits as a predictor for later development of the disorder (Saykin et al., 1994). In an
early review of attentional deficits in schizophrenia, 40 studies related to attentional
deficits in schizophrenia were examined (Cornblatt & Keilp, 1994). The results from this
meta-analysis indicated that attention is uniquely impaired in individuals with
schizophrenia, as compared to both healthy controls and individuals with major affective
disorders, and were predictive of later pathophysiology (Cornblatt & Keilp, 1994).
To further investigate this notion, efforts shifted toward identifying specific
attentional-deficit profiles in schizophrenia as compared to other psychiatric illnesses. In
a study that compared subjects with schizophrenia to subjects with major depression and
normal controls, subjects with schizophrenia demonstrated greater impairments in
attention and speed of processing than both healthy controls and subjects with depression
(Egeland et al., 2003). Although subjects with depression demonstrated similar
attentional deficits, these deficits were determined to be the result of lack of effort, rather
than caused by a manifestation of subcortical dysfunction (Egeland et al., 2003). In
addition to attention and speed of processing, subjects with schizophrenia also
demonstrated deficits in selective attention, which is indicative of an underlying
impairment in executive functioning (Nuechterlein et al., 2004).
One should note that the vast majority of studies that investigate attentional
deficits in schizophrenia simultaneously highlight deficits in memory, processing speed,
and even executive functioning. The reason is trifold: (a) cognitive deficits are not
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mutually exclusive constructs, despite neuropsychological assessments that attempt to
categorize them (Nuechterlein et al., 2004); (b) cognitive deficits are hierarchical in
nature, often having one (i.e., attention) as a prerequisite for another (i.e., memory;
Egeland et al., 2003); and (c) attempts to isolate cognitive deficits in research may limit
potential findings (Mass et al., 2000). Despite moderate correlations among cognitive
deficits, particularly those related to attention, multicollinearity is insufficient to suggest
true linear dependence (Shamsi et al., 2011). This notion does not necessarily support the
generalized-deficit approach, however. Rather, it is indicative of complex relationships
between and among cognitive deficits and clinical symptoms in schizophrenia that give
rise to the need for equally complex and nuanced subtypes meant to categorize them.
In fact, several studies have illustrated within-group differences with reference to
attentional deficits in schizophrenia (Braff, 1993; Carter et al., 2010; Lencz et al., 2006;
McGhie & Chapman, 1961; Nieuwenstein et al., 2001). One such study found statistically
significant differences between individuals with predominantly positive, as compared to
predominantly negative, symptoms (Nieuwenstein, Aleman, & de Haan, 2001).
Individuals who scored higher on measures of positive symptoms displayed poorer
performances on tests of attention and vigilance, such as the Continuous Pairs Test
(CPT), as compared to those with greater negative symptoms (Nieuwenstein et al., 2001).
Conversely, a similar study found differential impairments in attention for those with
greater negative symptoms as compared to positive symptoms (Liddle, 1987). Despite
these differences (i.e., greater negative symptoms vs. greater positive symptoms being
related to deficits in attention), consistent findings have confirmed the existence of
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differential impairments in attention as they relate to symptom dimensions, suggesting
domain specificity of within-group attentional deficits (Baxter & Liddle, 1998; Grube,
Bilder, & Goldman, 1998; Strauss, 1993).
Memory. Memory is related to attention and is defined in several ways within the
literature. Verbal memory, visual-episodic memory, short-term memory, and working
memory are all terms used to denote this cognitive domain in the schizophrenia literature.
Verbal memory and working memory, however, have been most consistently examined
and demonstrate differential impairments in schizophrenia as compared to both healthy
controls and individuals with other psychiatric illnesses (Lee & Park, 2005). Verbal
memory refers to an individual’s ability to recall without delay as many words as possible
from a list verbalized by an examiner, whereas working memory refers to one’s ability to
hold and manipulate information that is held in awareness (Heinrichs & Vaz, 2004).
Verbal memory is often assessed using the Hopkins Verbal Learning Test (HVLT), and
working memory is most often assessed using the Letter-Number Sequencing Test (LNS;
Keefe et al., 2003).
A meta-analysis that included 70 studies revealed a large effect size for both
verbal-memory and working-memory deficits in schizophrenia (Aleman, Hijman, de
Haan, & Kahn, 1999). These deficits were stable and widespread, despite differences in
moderating factors, such as illness duration (Aleman et al., 1999). Furthermore, findings
regarding memory deficits in schizophrenia are largely consistent across studies, despite
variations in assessment tools (Lee & Park, 2005). This variation demonstrates that
memory impairments in schizophrenia are significant enough to be detected across
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multiple measures and are thus modality independent (Park & Holzman, 1992). Similar
studies have demonstrated homogeneous findings, with large effect sizes for memory
impairments in schizophrenia (Achim & Lepage, 2005).
In addition to between-group differences, several studies have outlined memoryrelated deficits that are specific to individuals with predominantly negative symptoms
(Addington et al., 1991; Carter et al., 1996; Cuesta & Peralta, 1995; Milev, Ho, Arndt, &
Andreasen, 2005). One study in particular investigated the domain specificity of spatialworking-memory deficits in schizophrenia for nonmedicated subjects (Carter et al.,
1996). The results indicated that those with higher scores on negative-symptom
inventories produced lower scores on spatial-working-memory tasks, indicating that this
cognitive domain is differentially impaired in individuals with fewer positive symptoms
and greater negative symptoms (Carter et al., 1996). Additionally, these results suggest
that these differences stem from an organic, neuropathological origin rather than from
medication effects (Carter et al., 1996). Similar studies have had parallel findings
indicating a strong association between greater negative symptoms and poorer memory,
thus lending support to the domain-specific deficit theory (Addington et al., 1991; Cuesta
& Peralta, 1995; Milev et al., 2005).
Processing speed. Processing speed is positively correlated with memory and is
defined by one’s ability to quickly and correctly scan and process information. It is
typically assessed using timed digit-symbol coding tasks (Schatz, 1998). In Dickinson,
Ramsey, and Gold’s seminal meta-analytic study (2007), processing speed was identified
as the single largest cognitive deficit in schizophrenia (Dickinson et al., 2007). Compared
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to healthy controls, individuals with schizophrenia demonstrated significant impairment
in processing speed (Dickinson et al., 2007). The second largest effect size among the
cognitive domains was in executive-functioning tasks, such as category fluency, wherein
subjects are given 1 minute to generate as many unique words within a category as they
can (Dickinson et al., 2007). More recently, Knowles, David, and Reichenberg (2010)
replicated these findings after adding 11 studies to the original analysis. Their results
yielded an almost identical effect size of d = -1.50, indicating that processing speed is
consistently and significantly deficient in individuals with schizophrenia and is therefore
considered a hallmark of the disorder’s neurocognitive profile (Knowles et al., 2010).
In addition to studies that compared processing speed to other cognitive domains
in schizophrenia, researchers also examined longitudinal changes in relation to
processing-speed tasks. In a study that compared 95 hospitalized patients with
schizophrenia to 53 healthy age-matched controls, processing speed was found to be the
single best predictor of longitudinal outcomes of autonomy, self-care, vocational
functioning, and social functioning for individuals with schizophrenia (Sanchez et al.,
2009). Furthermore, studies suggest that processing speed mediates the relationship
between deficits in executive-functioning and functional outcomes and that processing
speed mediates a broader diversity of cognitive deficits overall (Ojeda et al, 2008).
Specifically, the severity of processing-speed deficits was predictive of the severity of
executive-functioning deficits (Ojeda, Pena, Sanchez, Elizagarate, & Ezcurra, 2008).
Additionally, within-schizophrenia differences were found among individuals
with greater negative symptoms. Similar to individuals with differential memory deficits,
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individuals who scored higher on measures of negative symptoms than positive
symptoms exhibited greater processing-speed deficits (Milev et al., 2005). An early study
examined the relationship between prognosis and processing speed. Prognosis was
defined by functional outcomes and severity ratings on clinical and cognitive symptoms
(Saccuzzo & Braff, 1981). The findings from this study illustrated differential
impairments within schizophrenia through identifying those with a poorer prognosis,
meaning those likely to have more severe clinical and cognitive symptoms as well as
poorer functional outcomes, as having slower processing speed (Saccuzzo & Braff,
1981). Those with a better prognosis, meaning those more likely to have better functional
outcomes and less severe cognitive and clinical symptoms as the disorder progressed, had
faster processing speed that could even be reversed with remediation and practice
(Saccuzzo & Braff, 1981). This finding indicates domain specificity for processing-speed
deficits within schizophrenia based on other disorder-related factors.
Executive functioning. Executive functioning is defined by tasks that require
complex thought and problem-solving abilities to carry out goal-directed thoughts and
behaviors (Kerns, Nuechterlein, Braver, & Barch, 2008). Executive functioning is
thought to engage several regions of the brain and has been consistently noted as a
cognitive-deficit domain in schizophrenia (Johnson-Selfridge & Zalewski, 2001. Much
like deficits in attention, deficits in executive functioning are present during the
prodromal phase of the disorder and have been found in adolescents at risk for
developing schizophrenia (Fossati, Amar, Raoux, Ergis, & Allilaire, 1999). Furthermore,
executive-functioning deficits in schizophrenia are often typified by psychosocial
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impairments and are more highly correlated with functional outcomes than any other
cognitive domain (Orellana & Slachevsky, 2013).
Executive functioning is measured by a variety of assessments, including the
Wisconsin Card Sorting Test (WCST), Trail Making B (TMB), and verbal/design fluency
tests (Minzenberg, Laird, Thelen, Carter, & Glahn, 2009). A meta-analysis that included
71 studies revealed that individuals with schizophrenia were impaired in executive
functioning relative to healthy controls (Johnson-Selfridge & Zalewski, 2001). Similarly,
individuals with schizophrenia performed 0.40 standard deviations below individuals
with other psychiatric illnesses on executive-functioning tasks (Johnson-Selfridge &
Zalewski, 2001).
Although deficits in executive functioning have been linked to a variety of
psychiatric illnesses, neuroimaging studies have illustrated that executive functioning is
differentially impaired in individuals with schizophrenia and that relationships between
executive functioning and psychiatric symptoms were evident (Elliott, 2003). Findings
from several studies indicate that executive-functioning deficits are differentially related
to negative symptoms rather than to positive symptoms in a way that suggests that
abstract reasoning and problem-solving abilities may be intact in individuals who are
high on positive symptoms and low on negative symptoms (Nieuwenstein & Aleman,
2001). A similar study also found that executive functioning was differentially impaired
for individuals with a greater number of hospitalizations and a varying degree of severity
of executive-functioning-deficit based on positive and negative symptom severity. These
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findings lend credence to the notion that positive symptoms are pathologically distinct
from other facets of the disorder (Nieuwenstein, Aleman, & de Haan, 2001).
Positive Symptoms
Positive symptoms have been the most widely studied feature of schizophrenia in
part because of their overt nature and amenability to assessment tools (Grube et al.,
1998). As a result, positive symptoms, particularly auditory hallucinations, have been
given precedence over other facets of the disorder (Millan, 2000). An earlier,
parsimonious model of schizophrenia attempted to dichotomize psychiatric symptoms
through introducing the positive-negative paradigm (Peralta, De Leon, & Cuesta, 1992).
This dichotomy was said to emerge as a result of the natural clustering of individuals into
either a positive-dominant or negative-dominant group (Liddle, 1987).
Most often in the literature, however, three symptom groups would emerge: (a)
individuals who scored high on assessments of positive symptoms, but low on
assessments of negative symptoms; (b) individuals who scored high on assessments of
negative symptoms, but low on positive symptoms; and (c) individuals who had roughly
equal scores on assessments of both positive and negative symptoms (Marneros &
Andreasen, 1992). Despite the inclusion of other variables and symptoms over time, the
positive-negative symptom paradigm continues to prevail in diagnostic manuals and
subsequent treatment strategies for schizophrenia.
Positive symptoms in schizophrenia include hallucinations, delusions, and
disorganized speech. More than 50% of all cases of schizophrenia have been reported to
include at least one positive symptom (David & Appleby, 1992). One of the largest
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criticisms of focusing solely on positive symptoms in schizophrenia is that they have
little clinical utility for predicting functional outcomes, whereas the same cannot be said
of other features of the disorder, such as negative symptoms and cognitive deficits
(Möller et al., 2000). Nonetheless, researchers continued to posit the high frequency,
good discriminability, and diagnostic utility of positive symptoms in schizophrenia
(Zimmerman, Favrod, Trieu, & Pomini, 2005).
While positive symptoms may be the most characteristic feature of schizophrenia,
their utility is limited to detecting the presence of the disorder (David & Appleby, 1992).
Positive symptoms alone are not practical markers for identifying schizophrenia
subtypes. Furthermore, positive symptoms respond better to psychopharmacological
interventions than any other feature of the disorder, and often require self-report as the
primary means to detect them (Andreasen & Flaum, 1991). Given that the majority of
individuals with schizophrenia are treated psychopharmacologically, positive symptoms
will be too transient to detect nuanced subtypes (McGlashan & Fenton, 1991).
Specifically, this method of identifying subtypes has been deemed phenomenologically
unstable and temporally unsound (McGlashan & Fenton, 1991). Positive symptoms are
only one facet of this complex disorder. Thus, identifying accurate and reliable subtypes
necessitates a comprehensive examination of the disorder in its entirety, including
positive symptoms, negative symptoms, and cognitive deficits.
Negative Symptoms
Negative symptoms of schizophrenia were originally conceptualized as secondary
features of the disorder (Andreasen, 1982). Negative symptoms include apathy, flattened
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affect, social withdrawal, and avolition (Erhart, Marder, & Carpenter, 2006). The
possibility that negative symptoms could be present in the absence of positive symptoms
soon became apparent, piquing clinical interest thereafter (Andreasen & Flaum, 1991).
Unlike positive symptoms, negative symptoms remain largely unaffected by
antipsychotic medications (Erhart et al., 2006). Their resistance to traditional treatment
methods, coupled with a growing emphasis on predicting functional outcomes, placed
negative symptoms at the forefront of schizophrenia research (Andreasen & Flaum,
1991).
Attempts to subtype schizophrenia through the examination of negative symptoms
soon emerged. Researchers believed that patients with predominant negative symptoms
belonged to a differentiated “deficit” subtype (Muesser, Douglas, Bellack, & Morrison,
1991). Longitudinal studies attempted to examine the influence of negative symptoms on
functional outcomes. The findings from these studies suggested that individuals with
many negative symptoms had poorer premorbid functioning, partial to no remissions
during the initial phase of the illness, and an overall progressive pathophysiology leading
to permanent disability (Fenton & McGlashan, 1991). Individuals with fewer negative
symptoms, however, demonstrated a better prognosis, acute onset, and more frequent
partial remissions (Fenton & McGlashan, 1991).
Despite some predictive utility, however, negative symptoms were neither
common enough nor specific enough to schizophrenia on their own to be useful in
identifying subtypes (Andreasen & Flaum, 1991). Studies that have examined the
reliability of using symptoms as markers of subtypes alone have demonstrated their lack
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of accuracy, soundness, and clinical utility (McGlashan & Fenton, 1991; Spitzer,
Endicott, & Robins, 1978), suggesting that a reductionistic model for identifying
subtypes of schizophrenia is unfeasible. Instead, the complexities inherent in the disorder
must be accounted for to produce a viable model for subtypes. This accountability
includes a holistic examination of psychiatric symptoms, both positive and negative, and
their relationships with cognitive deficits. Only a comprehensive review of the disorder
and its facets can yield a practical and valid basis for schizophrenia subtypes.
Relationship Between Psychiatric Symptoms and Cognitive Deficits
Once cognitive deficits were acknowledged as primary characteristics of
schizophrenia, researchers evaluated the relationship between cognitive deficits and
positive and negative symptoms (Strauss, 1993). In general, failures of information
processing and self-monitoring through interactions of frontal and septohippocampal
brain pathways are thought to be implicated in positive symptoms, whereas negative
symptoms relate to abnormal interactions between the frontal and striatal systems
(Strauss, 1993).
More specifically, positive symptoms are correlated with auditory-processing
deficits and broad neural networks that underlie attention (O’Leary et al., 2000), and
negative symptoms have been correlated with frontal-functional deficits (Gold, 2004). In
an attempt to further specify the nature of these relationships, studies looked to specific
symptoms within the positive-negative dichotomy. Namely, researchers determined that
hallucinations were correlated with information-processing deficits (i.e., an inability to
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accurately identify the source of the information), and delusions were related to abnormal
sensory input and faulty inference processes (Strauss, 1993).
Likewise, a study that compared 35 individuals with schizophrenia to 35 healthy
age-matched controls found that the individuals with schizophrenia had cognitive-deficit
profiles that were distinct from those of healthy controls and were specific to differential
symptom profiles (Brazo et al., 2002). Essentially, individuals in the schizophrenia group
who scored high on assessments of positive symptoms had some performances of
executive functioning in the normal range, indicating some preservation of cognitive
skills in that domain (Brazo et al., 2002). This finding is consistent with later reports that
suggest executive functioning is differentially impaired in individuals with stronger
negative symptoms than positive symptoms and further indicates that negative symptoms
have a stronger association than positive symptoms to cognitive deficits (Che et al., 2012;
Harvey, Green, Bowie, & Loebel, 2006).
The relationship between negative symptoms and cognitive deficits has attracted
much interest in the past 15 years. Though whether these variables are essentially
defining the same construct has been debated, negative symptoms have been widely
accepted as conceptually distinct from cognitive deficits (Brazo et al., 2002). One of the
most significant findings drawn from this literature is that negative symptoms and
cognitive deficits are correlated in severity on a cross-sectional basis and that both are
highly correlated with functional outcomes (Harvey et al., 2006). Although these
constructs seem to overlap, support for models that conceptualize negative symptoms and
cognitive deficits as two separate dimensions of schizophrenia rests in their divergent
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neuropathology and subsequent variation in associated affected brain regions (Harvey et
al., 2006).
Previous studies have reached similar conclusions regarding the correlations
between negative-symptom severity and cognitive-deficit severity. Upon evaluating 38
individuals with schizophrenia at two time periods, analyses revealed that higher ratings
of negative symptoms were more likely to be associated with cognitive deficits as
compared to higher ratings of positive symptoms (Addington et al., 1991). Likewise, a
cross-sectional analysis found similar associations between positive symptoms and
cognitive deficits, though positive symptoms were also correlated with cognitive deficits
in the attention and memory domains (Savilla, Kettler, & Galletly 2008). Most
consistently, research has highlighted the relationship between negative symptoms and
deficits in visuospatial-constructional skills, language, and executive functioning and the
relationship between positive symptoms and deficits in memory and attention (Milev et
al., 2005). Processing speed has been shown to be impaired in both positive-symptomdominant and negative-symptom-dominant profiles (Bowie et al., 2008). An overview of
these associations from the most seminal studies are outlined in Table 1.
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Table 1
Outcomes of Studies Assessing the Relationship Between Psychotic Symptoms and
Cognitive Deficits in Schizophrenia from 1991-2004
Study

Assessment
measures

Symptom
outcomes

Cognitive
outcomes

Combined symptom
and cognitive
outcomes

Mahurin
et al.,
1998

Symptom:
BPRS
Cognitive:
TMT, visual
search,
verbal
fluency,
HVLT,
WCST,
stroop, digit
span, digit
symbol

Factor loadings
revealed 3
distinct
symptom
groups with
highest ratings:
(a) Withdrawal
(b) Conceptual
disorganization
, (c) Reality
distortion

Deficits identified 1. Withdrawal
in processing
(negative)
speed, attention/
symptom group
vigilance, and
associated with
verbal memory
deficits in verbal
memory and
processing speed
2. Conceptual
disorganization
(positive) symptom
group associated
with deficits in
verbal memory and
attention/vigilancea
3. Reality distortion
(positive) symptom
group associated
with deficits in
verbal memory a

Heydebra
nd et al.,
2004

Symptom:
PANSS
Cognitive:
WMS-R,
WCST,
RAVLT,
CPT-IP,
stroop

2 general
symptom
groups:
Negative
symptoms and
positive
symptoms

Differential
impairments
identified in
memory,
attention, verbal
fluency,
psychomotor
speed, and
executive
function

1. Higher rates of
negative symptoms
were associated
with deficits in
memory, verbal
fluency,
psychomotor
speed, and
executive function
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Assessment
measures

Addington Symptoms:
et al.,
SAPS,
1991
SANS
Cognitive:
WAIS, Rey’s
complex
figure, word
fluency,
design
fluency,
WCST
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Symptom
outcomes

Cognitive
outcomes

Combined symptom
and cognitive
outcomes

2 general
symptom
groups:
Negative
symptoms and
positive
symptoms

Differential
impairments
identified in
general
intellectual
functioning (IQ),
executive
functioning,
verbal fluency,
and memory

1. High rates of
negative symptoms
and low rates of
positive symptoms
were more likely to
be associated with
lower general IQ
and deficits in
executive
functioning
2. Higher rates of
positive symptoms
were associated
with deficits in
verbal memory a
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Assessment
measures

Symptom
outcomes

Berman et Symptom:
1. 3 groups:
al., 1997
PANSS
positive
Cognitive:
symptoms,
WCST,
negative
TMT, WAISsymptoms,
R, verbal
mixed
fluency, digit
positive and
span, digit
negative
symbol,
symptoms
block design, 2. Positive and
visual recall/
negative
recognition
symptoms
showed a
trend toward
direct
correlation (r
= .30), but
were
associated
with
different
cognitive
deficits

Cognitive
outcomes
Differential
impairments
identified in
executive
functioning,
visuospatial
constructional
skills, verbal
memory, and
attention
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Combined symptom
and cognitive
outcomes
1. Higher rates of
negative symptoms
are more likely to
be associated with
deficits in
executive
functioning and
deficits in
visuospatial
constructional skilla
2. Higher rates of
positive symptoms
are more likely to
be associated with
deficits in verbal
memory and
auditory attention a
3. No associations
were found
between positive/
negative symptoms
and global
functioning (i.e.,
IQ)

IDENTIFYING SUBTYPES OF SCHIZOPHRENIA

34

Study

Assessment
measures

Symptom
outcomes

Cognitive
outcomes

Combined symptom
and cognitive
outcomes

Cuesta &
Peralta,
1995

Symptom:
SAPS,
SANS
Cognitive:
Luria’s test
(executive
functioning),
verbal
memory,
visual
memory,
digit symbol,
TMT, Rey’s
complex
figure, facematching
test

3 groups
“syndromes”:
positive
syndrome,
negative
syndrome, and
disorganized
syndrome

Differential
impairments
identified in
visual-motor
performance,
verbal memory,
attention, and
processing speed

1. Higher rates of
positive symptoms
were correlated
with better
performances on
visual-motor tasks
2. Higher rates of
negative symptoms
were correlated
with worse
performances on
visual-motor tasks
3. Higher rates of
disorganized
symptoms were
associated with
worse
performances on
visual-motor
functioning,
processing speed,
and verbal memory
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O’Leary
et al.,
2000

Assessment
measures

Symptom
outcomes

Symptom:
SAPS,
SANS
Cognitive:
WAIS-R,
WCST,
TMT, CPT,
logical
memory, list
learning,
verbal
fluency,
stroop, Rey’s
complex
figure

3 groups
“syndromes”:
positive
syndrome,
negative
syndrome, and
disorganized
syndrome

Cognitive
outcomes

35
Combined symptom
and cognitive
outcomes

Deficits identified 1. Negative symptoms
in verbal fluency,
were correlated
verbal memory,
with greater
processing speed
deficits in verbal
memory, nonverbal
memory, verbal
fluency, and
processing speed
2. Disorganized
symptoms were
correlated with
greater deficits in
executive
functioning and
global functioning
(i.e., IQ)
3. Positive symptoms
were correlated
with better
performances on
the Rey’s complex
figure drawing test
(visual-motor
memory)

Note., BPRS = Brief Psychiatric Rating Scale, TMT = Trail Making Test, HVLT =
Hopkins Verbal Learning Test, WCST = Wisconsin Card Sorting Test, PANSS = Positive
and Negative Syndrome Scale, WMS-R = Wechsler Memory Scale-Revised, RAVLT = Rey
Auditory Verbal Learning Test, CPT = Continuous Performance Test, CPT-IP =
Continuous Performance Test-Identical Pairs, SAPS = Scale for the Assessment of
Positive Symptoms, SANS = Scale for the Assessment of Negative Symptoms, WAIS =
Wechsler Adult Intelligence Scale, WAIS-R = Wechsler Adult Intelligence Scale-Revised.
a indicates patterns of similar findings across studies.

Summary
Despite overt and reliable associations between psychiatric symptoms and
cognitive deficits, researchers have yet to utilize these associations as a means to identify
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subtypes and thereby decrease the widespread heterogeneity that has impeded treatment
success in schizophrenia (Kraus & Keefe, 2007). Three general factors related to
treatment success in schizophrenia have been identified in the literature: treatment-related
factors, patient-related factors, and system-related factors, such as access to care,
socioeconomic status, and level of education (Buckley, 2008). Specifically, utilizing
generic treatment protocols without regard for patient-specific variables has led to limited
treatment success (Buckley, 2008). This limited success has resulted from a lack of
diagnostic precision; unspecific treatment aims; and the employment of singular,
symptom-focused interventions (Kraus & Keefe, 2007).
Global perspectives lead to problematic, generalized treatments that hinder
functional outcomes. Thus, the need to identify subtypes in schizophrenia is trifold: (a) to
improve diagnostic clarity and accuracy, (b) to improve treatment outcomes, and (c) to
better the etiological understanding of schizophrenia as a means to support risk and
prevention strategies. Support for this tripartite reasoning rests in failed attempts at
establishing subtypes of schizophrenia in the past through simplistic models that focused
on only one dimension (i.e., clinical symptoms) of schizophrenia. Chiefly, these failures
have resulted from oversimplifying the facets of the disorder through a psychiatric
symptom-only focus (Keefe & Fenton, 2007). Owing to treatment response and
occasional symptom overlap, positive and negative symptoms are unreliable and
insufficiently equipped to identify subtypes of schizophrenia in isolation (Liddle, 1987).
Instead, the identification of subtypes in schizophrenia requires an all-inclusive model
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wherein differential profiles of neurocognition and psychiatric symptoms are taken into
account.
The first step toward achieving this goal requires an examination of the
relationships between psychiatric symptoms and cognitive deficits in schizophrenia.
Next, a broader examination of these relationships should be applied to identify a
clustering of homogenous groups, meaning that within these symptom-deficit
relationships distinct subtypes will emerge.
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Chapter 3: Hypotheses
1. It is hypothesized that negative symptoms of psychosis will be positively correlated
with deficits in executive functioning and processing speed for individuals with a
diagnosis of schizophrenia, as supported by the literature. This hypothesis is in
accordance with previous studies in which distinct neurological substrates are
associated with negative, as compared to positive, psychiatric symptoms in
schizophrenia (Addington et al., 1991; Berman et al., 1997; Brazo et al., 2002; Cuesta
& Peralta, 1995; Mahurin, Velligan, & Miller, 1998; O’Leary et al., 2000).
2. It is further hypothesized that positive symptoms of psychosis will be positively
correlated with attentional and memory-related cognitive deficits for individuals with a
diagnosis of schizophrenia, as supported by numerous study findings (Addington et al.,
1991; Berman et al., 1997; Brazo et al., 2002; Cuesta & Peralta, 1995; Mahurin,
Velligan, & Miller, 1998; O’Leary et al., 2000).
3. It is equally hypothesized that the application of a cluster analysis will reveal clinical
subtypes of schizophrenia through identifying differential neurocognitive and
symptomatic profiles that reflect the aforementioned correlations.
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Chapter 4: Methodology
Participants
The present study used a secondary analysis of data collected by the NIMHfunded Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Study, which
was a nationwide, public-health clinical trial designed to measure the comparative
effectiveness of first- and second-generation antipsychotic medications. The CATIE study
took place between January 2001 and December 2004 at 57 clinical sites in the United
States. Patients were randomized algorithmically under double-blind conditions to
receive one of five antipsychotic medications. Eligible participants from the original
study (N = 1,460) were aged 18 to 65 years and met Diagnostic and Statistical Manual of
Mental Disorders (4th ed.; DSM-IV; American Psychiatric Association, 1994) criteria for
schizophrenia as determined by the Structured Clinical Interview for DSM-IV Axis I
disorders (SCID-I). The original clinical sites involved in recruitment included 16
university clinics, 10 state mental-health agencies, seven Veterans Affairs Medical
Centers, six private nonprofit agencies, four private-practice sites, and 14 mixed-system
sites. Primary demographic and clinical characteristics are outlined in Table 2.
To eliminate potential confounds inherent in incorporating preexisting categorical
differentiations among DSM-IV categories, only individuals with a primary diagnosis of
schizophrenia were included in the current study. Individuals with a diagnosis other than,
or secondary to, schizophrenia as indicated by the SCID-I were excluded. Furthermore,
patients with a diagnosis of mental retardation or other cognitive disorders; patients with
a history of only one schizophrenic episode; or those with a serious or unstable medical
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condition were excluded. Additionally, only individuals with complete neurocognitive
and symptomatic data were included in the current study.
Measures
Positive and Negative Syndrome Scale (PANSS)
The Positive and Negative Syndrome Scale (PANSS; Kay, Fiszbein, & Opler,
1987) is a 30-item, rater-administered scale designed to assess three dimensions of
psychosis: positive symptoms, negative symptoms, and general psychopathology (Kay et
al., 1987). Each item (symptom) is accompanied by a definition and specific anchoring
criteria to assist in scoring. Items are scored on a 7-point Likert scale ranging from 1
(absent) to 7 (extreme). Anchoring criteria are provided for all seven rating points. Of the
30 total items, seven items correspond to positive symptoms, another seven items
correspond to negative symptoms, and the remaining 16 items correspond to general
psychopathology. A total symptom severity score is yielded by averaging all 30 item
ratings.
The PANSS has been used widely in clinical studies of psychosis and has
demonstrated reliability across a variety of patient populations. The average interrater
reliabilty for the PANSS is strong (0.82; Kay, Opler, & Lindenmayer, 1988). At present,
the PANSS is the most frequently used assessment of psychotic symptoms, and it has
consistently demonstrated reliable and valid psychometric properties that are over and
above those of similar instruments, such as the Brief Psychotic Rating Scale (BPRS)
(Faustman & Overall, 1999).
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Continuous Performance Test, Identical Pairs Versions (CPT-IP)
The Continuous Performance Test, Identical Pairs Versions (CPT-IP; Cornblatt,
Risch, Faris, Friedman, & Erlenmeyer-Kimling., 1988) is an assessment that measures
attention and vigilance. The CPT-IP has three conditions that are comprised of 150 trials
each. The trials increase in difficulty as the task progresses. The CPT-IP requires the
participant to identify identical pairs within a continuous presentation of stimuli. Each
stimulus is presented on a computer screen at the rate of one stimulus per second
(Cornblatt et al., 1988). The first condition presents two-digit numbers continuously, and
the participant is asked to raise his or her finger each time a number presented is identical
to the previous number presented. The second condition uses three-digit numbers, and the
third condition uses four-digit numbers. The CPT-IP was normed on a schizophrenia and
major-affective-disordered population and has high test-retest reliability (Cornblatt et al.,
1988). The CPT-IP is scored by the total number of correctly identified pairs, ranging
from 0 to 30, with higher scores indicating better attentional capacity (Cornblatt et al.,
1988).
Wechsler Adult Intelligence Test-Revised (WAIS-R) Digit Symbol Test
The Wechsler Adult Intelligence Test-Revised (WAIS-R) Digit Symbol Test
(Wechsler, 1955) is an assessment of processing speed in which participants are presented
with numbers and associated symbols. The participant’s task is to copy as many symbols
associated with numerals as possible in 90 seconds. The score is derived from the sum of
correctly copied symbols, ranging from 0 to125, with higher scores indicating faster
processing speed. The digit symbol subtest on the WAIS-R is considered to be one of the
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most reliable indicators of processing speed in a psychiatric inpatient sample with a large
reliability coefficient (.77; Boone, 1992).
Wisconsin Card Sorting Test, 64-Card Computerized Version (WCST-64P)
The Wisconsin Card Sorting Test, 64-Card Computerized Version (WCST-64P;
Kongs, Thompson, Iverson, & Heaton, 2000) is a measure of executive functioning. The
WCST-64P requires complex categorization and problem solving based on the
examiner’s feedback. The participant is initially presented with four different cards that
remain on the screen. The computer then presents one card at a time, and the participant’s
task is to match the current card to one of the original four. After the participant makes
his or her choice, the computer says either “correct” or “incorrect” without further
instruction. The cards are appropriately matched on three rules: color, shape, and number.
The rule changes after 10 consecutive correct responses throughout the administration,
without the participant knowing. The WCST-64P is scored by averaging the number of
perseverative errors and the number of categories, or rules, completed. Higher scores
indicate better executive functioning. Scores are compared to the corresponding norms
located in the manual to determine relative interpretations. The WCST-64P has
demonstrated high reliability and validity in psychiatric populations (Lysaker & Bell,
1994).
Hopkins Verbal Learning Test (HVLT)
The Hopkins Verbal Learning Test (HVLT; Brandt & Benedict, 1991) is an
assessment of verbal memory. The examiner reads aloud a list of 12 words. The
participant is then asked to recall as many words as possible. There is a total of four trials,
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with the same set of 12 words read at the start of each trial. The HVLT is scored by the
sum of words correctly recalled across all four trials. Higher scores indicate better verbal
learning and verbal memory and can be compared to the norms provided in the manual to
make interpretations relative to an age-matched sample. Scores range from 0 to 36. The
HVLT was designed for repeated testing and demonstrates high test-retest reliability
(Benedict, Schretlen, Groninger, & Brandt, 1998).
Letter-Number Span Test of Auditory Working Memory
The Letter-Number Span Test of Auditory Working Memory (Gold, Carpenter,
Randolph, Goldberg, & Weinberger, 1997) is an assessment of working memory.
Participants are aurally presented with sequences of letters and numbers combined (e.g.,
N6G2). Participants are then asked to reorder the sequences by stating the numbers first,
from lowest to highest, followed by the letters in alphabetical order. The Letter-Number
Span Test of Auditory Working Memory is scored by the sum of correct sequences.
Scores range from 0 to 21, where higher sums indicate better working memory. This
assessment has been widely used in the schizophrenia population and demonstrates high
test-retest reliability (Nuechterlein et al., 2008).
Computerized Test of Visuospatial Working Memory
The Computerized Test of Visuospatial Working Memory (Hershey, Selke,
Fucetola, & Newcomer, 1999) is an assessment of working memory with visual stimuli.
The participant must focus on a central cross fixation point on a computer screen while a
cue appears for 150 milliseconds in one of 32 possible locations around the cross. After a
delay period of 5 or 15 seconds, the participant must identify, via pointing, where on the
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computer screen they remember seeing the cue. There are eight trials total. The
Computerized Test of Visuospatial Working Memory is scored by the mean error in
millimeters of the distance between the recalled cue point and the actual cue point.
Higher scores, or mean error rates, indicate poorer visuospatial working memory. Mean
error rates can be compared to the normative data provided in the manual for
interpretation. This test is considered to be a reliable and valid indicator of one’s
visuospatial working memory (Keefe et al., 2003).
Procedure
The parent study used a Neurocognitive Assessment Unit evaluator to determine
proficiency of each tester before the initiation of the trial at its site. The performance of
these testers were monitored throughout the study via reviews of their protocols and
scoring sheets. Raw data collected from each site were entered into a web-based data
entry system. To the extent possible, each participant was rated by the same examiner
across all assessments. The timing of the assessments occurred at baseline, 2 months, 6
months, and 18 months or end of study. For the purposes of this study, only data collected
at the baseline neurocognitive trials were used. The purpose of using only baseline trials
was to minimize the possibility of medication effects on cognitive performance, being
that the original study trialed typical and atypical antipsychotic medications. By using
baseline data only, participants would have been functioning under their usually
prescribed, stabilized medication, which may be an atypical or typical antipsychotic.
Being that most individuals with schizophrenia are medicated on one of these two types
of antipsychotics, this sample should accurately represent the population, and thus have
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good generalizability. The procedure for the present study included entering the symptom
and neurocognitive data into a cluster analysis via SPSS. This study is the first known
report of identifying subtypes based on differential neurocognitive profiles in relation to
symptom patterns from this archival dataset. The dataset was obtained through NIMH via
a Data Use Certificate (DUC) request in which the study’s aims, investigators, and
potential implications were outlined. Upon review by the NIMH, the DUC was approved
pending IRB approval, and access codes were provided to the primary investigators to
access the data via a web-based system. An expedited application was placed with the
IRB board at Philadelphia College of Osteopathic Medicine before the data were
accessed.
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Chapter 5: Statistical Plan
Descriptive analyses were performed on demographic variables, such as age,
gender, and ethnicity.
Hypothesis 1
The first goal of this study was to identify the relationship between negative
symptoms of psychosis and distinct neurocognitive deficits. Both symptom scores and
neurocognitive scores are continuous measures; therefore, a Pearson correlation was used
to identify the relationship between negative symptoms and neurocognitive domains
using SPSS.
Hypothesis 2
The second goal of this study was akin to the first, that is, to identify the
relationship between positive symptoms of psychosis and distinct neurocognitive deficits.
The statistical analysis to examine this aim mirrored that of the first. To identify the
relationship between positive symptoms and neurocognitive domains, a Pearson
correlation was conducted in SPSS.
Hypothesis 3
The primary aim of this study was to identify subtypes of schizophrenia through
identifying homogenous groups that cluster together based on both symptomatic and
neurocognitive data. To identify homogenous subtypes of patients that are independent
from each other, four cognitive domains and two symptom domains were entered into a
cluster analysis using SPSS. The four cognitive domains included attention, processing
speed, executive functioning, and memory. The two symptom domains included positive
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and negative symptom categories based on the PANSS. The simplest interpretable
solution that fit the data was chosen, and each patient was assigned to the most congruent
cluster. Listwise deletion was employed for participants with missing values in any
domain.
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Chapter 6: Results
Descriptive Statistics
A total of 1,147 participants from the parent study met the inclusionary and
exclusionary criteria for the present study. Demographics of study participants are
outlined in Table 2. Of the participants, 74.4% were male and 25.1% were female. The
average age of the participants was approximately 40 years old, with a range of 18 to 67
years old. Participants averaged 11.62 total years of education, with a range of 1 to 21
years of education, and had an average of 13.6 years since first prescribed antipsychotic
medication. A majority of the participants were unemployed (82.9%). The sample
consisted of 61.6% of people who identified as Caucasian, 33.1% who identified as
African American, and 2.4% who identified as Asian. Unknown race accounted for 0.5%
of participants.

Table 2
Demographic Characteristics of CATIE Participants with Neurocognitive Data
Participants with complete data
(N = 1,147)
Variable

Mean

SD

Age (years)

40.20

10.86

Patient’s education (years)

11.62

3.51

Duration since first prescribed antipsychotic
medication (years)

13.60

10.45

Sex

n

% Frequency

Male

853

74.4

Female

288

25.1
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Participants with complete data
(N = 1,147)

Race

Unknown

2

0.5

White

706

61.6

Black

380

33.1

Asian

27

2.4

Unknown

7

0.6

Full time

81

7.1

102

8.9

951

82.9

Employment status

Part time
Unemployed

Note. CATIE = Clinical Antipsychotic Trials of Intervention Effectiveness

Hypothesis 1
A Pearson correlation was conducted to evaluate the relationship between
negative psychiatric symptom scores and scores on cognitive-deficit domain measures.
The results demonstrated significant negative correlations between negative symptoms of
psychosis and all cognitive-deficit domains identified for this study: Attention/Vigilance,
Processing Speed, Reasoning/Problem Solving, Memory, and overall Neurocognitive
Composite score (see Table 3).
Specifically, the results indicated a significant negative correlation between
negative symptoms of psychosis and Attention/Vigilance, r = -.202, p < .01 (see Table 3).
This negative correlation suggests that participants with higher scores of negative
symptoms had lower scores on measures of attention.
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The results also indicated a significant negative correlation between negative
symptoms of psychosis and Processing Speed, r = -.262, p < .01 (see Table 3). This
negative correlation suggests that participants with greater negative symptoms of
psychosis had lower scores on measures of speed of processing.
Similarly, a significant negative correlation was also identified in relation to
negative symptoms of psychosis and Reasoning/Problem Solving, r = -.118, p < .01 (see
Table 3). This negative correlation indicates that participants with greater negative
symptoms scored lower on reasoning and problem-solving measures.
A significant negative correlation was also found between negative symptoms of
psychosis and Memory, r = -.191, p < .01 (see Table 3). These results suggest that
patients with greater negative psychotic symptoms scored lower on memory measures.
Finally, a significant negative correlation was identified between negative
symptoms of psychosis and overall Neurocognitive Composite scores, which are an
average of one’s cognitive abilities on the whole, r = -.260, p < .01 (see Table 3). This
negative correlation suggests that individuals with greater negative symptoms of
psychosis perform lower across all cognitive domains.
Table 3
Hypothesis 1: Correlation Matrix for Variables with Negative Symptoms of Psychosis
Variable
NEGSX
ATT/V
PSP
R/PS

NEGSX
---

ATT/V

PSP

R/PS

MEM

NCOMP

-.202**

-.262**

-.118**

-.191**

-.260**

---

.576**

.388**

.514**

.745**

---

.520**

.607**

.838**

---

.504**

.718**

IDENTIFYING SUBTYPES OF SCHIZOPHRENIA
Variable

NEGSX

ATT/V

PSP

MEM
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R/PS

MEM

NCOMP

---

.819**

NCOMP

---

Note. N = 1,147 .NCOMP = Neurocognitive Composite Score, NEGSX = Negative symptoms of
psychosis, Positive and Negative Syndrome Scale (PANSS; Kay, Fiszbein, & Opler, 1987). ATT/V =
Attention/Vigilance, Continuous Performance Test, Identical Pairs Versions (CPT-IP; Cornblatt et al.,
1988). PSP = Processing speed, The Wechsler Adult Intelligence Test-Revised (WAIS-R) Digit Symbol Test
(Wechsler, 1955). R/PS = Reasoning and problem solving, The Wisconsin Card Sorting Test, 64-Card
Computerized Version (WCST-64P; Kongs et al., 2000). MEM = Memory, The Hopkins Verbal Learning
Test (HVLT; (Brandt & Benedict, 1991), The Computerized Test of Visuospatial Working Memory
(Hershey et al., 1999).
* p < .05. **p < .01.

Hypothesis 2
A Pearson correlation was conducted to evaluate the relationship between positive
psychiatric symptom scores and scores on cognitive-deficit domain measures. In
particular, a Pearson correlation was conducted to determine relationships, if any,
between positive symptoms of psychosis and cognitive-deficit domains identified for this
study, including Attention/Vigilance, Processing Speed, Reasoning/Problem Solving,
Memory, and overall Neurocognitive Composite. Of the cognitive-deficit domains, only
Memory had a significant relationship with positive symptoms of psychosis. Specifically,
the results indicated a significant negative correlation between positive symptoms of
psychosis and Memory, r = -.067, p < .05 (see Table 4). This correlation suggests that
participants with higher scores on positive symptom measures had lower scores on
measures of memory.
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In contrast, the results indicated no significant relationships between positive
symptoms of psychosis and Attention/Vigilance or Processing Speed, r = -.001, p = .965,
and r = .021, p = .488, respectively (see Table 4).
Furthermore, no significant relationship was identified between positive
symptoms of psychosis and Reasoning/Problem Solving or overall Neurocognitive
Composite scores, r = -.010, p = .726, and r = -.026, p = 0.382, respectively (see Table 4).

Table 4
Hypothesis 2: Correlation Matrix for Variables with Positive Symptoms of Psychosis
Variable
POSSX
ATT/V
PSP

POSSX
---

ATT/V
-0.001
---

PSP

R/PS

MEM

NCOMP

0.021

-0.010

-.067*

-0.026

.576**

.
388**

---

R/PS

.520**
---

MEM

.514**

.745**

.607**

.838**

.504**

.718**

---

NCOMP

.819**
---

Note. N = 1,147. NCOMP = Neurocognitive Composite Score, POSSX = Positive symptoms of psychosis,
Positive and Negative Syndrome Scale (PANSS; Kay, Fiszbein, & Opler, 1987). ATT/V = Attention/
Vigilance, Continuous Performance Test, Identical Pairs Versions (CPT-IP; (Cornblatt et al., 1988). PSP =
Processing speed, The Wechsler Adult Intelligence Test-Revised (WAIS-R) Digit Symbol Test (Wechsler,
1955). R/PS = Reasoning and problem solving, The Wisconsin Card Sorting Test, 64-Card Computerized
Version (WCST-64P; Kongs et al., 2000). MEM = Memory, The Hopkins Verbal Learning Test (HVLT;
Brandt & Benedict, 1991), The Computerized Test of Visuospatial Working Memory (Hershey et al., 1999).
* p < .05. **p < .01.

Hypothesis 3
A nonhierarchical K-mean cluster analysis was performed to identify homogenous
groups based on standardized scores across all neurocognitive and symptom domains.
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The clustering method used assumes a number of clusters (K) apriori. Each data point is
subsequently combined with other data points with the closest Euclidean distance to the
K cluster center. Cluster cohesion was optimal at the two-cluster level (i.e., K = 2), as the
Cluster 1 and Cluster 3 solutions did not create cohesive clusters. Closeness was
determined by identifying the centroids of each cluster. Centroids are artificial data points
that represent the average of all data points in the cluster. Once the centroids were
determined, Euclidean distance of each data point from its centroid was then calculated,
producing successive iterations until the maximum number of iterations was achieved
(Table 5). The maximum number of iterations performed was 10, and the iterations failed
to converge. Nonetheless, each successive iterative yielded a smaller variance, indicating
strong cohesion between each data point and its assigned cluster. The maximum absolute
coordinate change for any center was .010, with the minimum distance between initial
cluster centers being 10.889.

Table 5
Hypothesis 3: Iteration History of Change in Cluster Centers

Iteration

Change in Cluster Centers
Cluster 1

Cluster 2

1

4.856

4.158

2

.314

.201

3

.156

.105

4

.068

.046

5

.045

.031
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.045

.033

7

.037

.027

8

.029

.022

9

.017

.013

10

.015

.012
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The final cluster centers differed on the two variables of interest: cognitive
domains and psychotic symptoms. That is, Cluster 1 was representative of participants
who scored high on both positive and negative symptoms of psychosis and were more
compromised across all cognitive domains as compared to Cluster 2. Conversely, Cluster
2 was representative of participants who had a lower presence of both positive and
negative symptoms and displayed better cognitive functioning overall. These differences
are noted in Table 6.
Table 6
Hypothesis 3: Final Cluster Centers from the K-Means Cluster Analysis (N = 1,147)
Variable

Cluster 1

Cluster 2

ATT/V

-.661

.525

PSP

-.773

.608

R/PS

-.614

.483

MEM

-.764

.601

NEGSX

.368

-.289

POSSX

.094

-.074

Note. NEGSX = ATT/V = Attention/Vigilance, Continuous Performance Test, Identical Pairs Versions
(CPT-IP; Cornblatt et al., 1988). PSP = Processing speed, The Wechsler Adult Intelligence Test-Revised
(WAIS-R) Digit Symbol Test (Wechsler, 1955). R/PS = Reasoning and problem solving, The Wisconsin
Card Sorting Test, 64-Card Computerized Version (WCST-64P; Kongs et al., 2000). MEM = Memory, The
Hopkins Verbal Learning Test (HVLT; Brandt & Benedict, 1991) & The Computerized Test of Visuospatial
Working Memory (Hershey et al., 1999). Negative symptoms of psychosis, POSSX = Positive symptoms of
psychosis, Positive and Negative Syndrome Scale (PANSS; Kay, Fiszbein, & Opler, 1987).
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A posthoc analysis was performed by way of an analysis of variance (ANOVA)
between Cluster 1 and Cluster 2. The ANOVA supported the cluster findings, as
evidenced by significant differences across all variables between clusters. The effect size,
calculated using eta squared, was large for all four cognitive domains and small for
positive and negative symptoms. Findings from the ANOVA are summarized in Table 7.
Table 7.
Hypothesis 3: Analysis of Variance (ANOVA) Between Cluster 1 and Cluster 2
Mean
square

df

Mean
square

df

F

Sig.

Eta
squared

ATT/V

393.040

1

.657

1143

598.227

.000**

0.225

PSP

537.625

1

.531

1143

1013.409

.000**

0.372

R/PS

339.884

1

.704

1143

483.124

.000**

0.341

MEM

525.410

1

.541

1143

970.828

.000**

0.351

NEGS
X

121.766

1

.894

1143

136.151

.000**

0.098

POSS
X

7.934

1

.994

1143

7.982

.005*

0.015

Note. N = 1,147. ATT/V = Attention/Vigilance, Continuous Performance Test, Identical
Pairs Versions (CPT-IP; Cornblatt et al., 1988). PSP = Processing speed, The Wechsler
Adult Intelligence Test-Revised (WAIS-R) Digit Symbol Test (Wechsler, 1955). R/PS =
Reasoning and problem solving, The Wisconsin Card Sorting Test, 64-Card Computerized
Version (WCST-64P; (Kongs et al., 2000). MEM = Memory, The Hopkins Verbal Learning
Test (HVLT; Brandt & Benedict, 1991) & The Computerized Test of Visuospatial Working
Memory (Hershey et al., 1999). NEGSX = Negative symptoms of psychosis, POSSX =
Positive symptoms of psychosis, Positive and Negative Syndrome Scale (PANSS; Kay,
Fiszbein, & Opler, 1987).
* p < .05. **p < .01.

A chi-square analysis using cross-tabulation was performed to determine whether
the clusters differed on demographic variables. The differences between clusters based on

IDENTIFYING SUBTYPES OF SCHIZOPHRENIA

56

race were significant. That is, Cluster 2, which was determined to be less compromised
overall, was comprised of significantly more White participants than Black participants
as compared to Cluster 1, (Χ2(7) = 33.049, p < .001; see Table 8). Employment was also
found to be significantly different between the two clusters. Specifically, participants in
Cluster 2 were more likely to have a work history as compared to those in Cluster 1,
(Χ2(4) = 16.940, p = .002; see Table 9). Gender was not significantly different between
the two clusters.
Table 8.
Chi-Square Analysis for Race
Value

df

Asymptotic significance

Pearson chi-square

33.049a

7

.000

Likelihood ratio

35.009

7

.000

N of valid cases

1,145

Note. a Eight cells (50.0%) have expected count less than 5. The minimum expected count is .88.

Table 9.
Chi-Square Analysis for Employment
Value

df

Asymptotic significance

Pearson chi-square

16.940a

4

.002

Likelihood ratio

17.524

4

.002

N of valid cases

1,145

Note. Four cells (40.0%) have expected count less than 5. The minimum expected count is 1.76.

Next, a multivariate analysis of variance (MANOVA) was performed to test
differences between the clusters on two variables: (a) the number of years since first
prescribed antipsychotic medication, and (b) number of years of education. However, a
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significant Levene’s test, F = 20.25, p < .001, indicated a violation of the homogeneity of
variance, prompting the use of a Welch’s t test. Findings from the Welch’s t test (see
Table 10) indicate significant differences between the two clusters on these variables.
That is, the participants in the more compromised group (Cluster 1) have fewer years of
education, t(972.03) = -5.92, p < .001, and more years since first prescribed antipsychotic
medication, t(924.80) = 7.53, p < .001, as compared to the less compromised group
(Cluster 2).

Table 10.
Independent Samples Test Between Education Years and Years Prescribed
Levene’s test for equality of
variances

Educatio
n years

Equal
variances
assumed

F

Sig.

t

df

Sig.

Mean
Differenc
e

20.25

.000

-6.0
3

1132

.000

-1.25

.207

-5.9
2

972

.000

-1.25

.211

7.72

1112

.000

4.75

.615

7.53

924

.000

4.75

.631

Equal
variances
not
assumed
Yrs_pres

Equal
variances
assumed
Equal
variances
not
assumed

t-test for equality of
means

28.34

.000

Std. Error
Differenc
e

Note. Education years = Number of years of education. Yrs_pres = Number of years since
first prescribed antipsychotic medication

IDENTIFYING SUBTYPES OF SCHIZOPHRENIA

58

Chapter 7: Discussion
The present study aimed to categorize subtypes of schizophrenia based on
differences in two symptom types: cognitive deficits and positive and negative symptoms
of psychosis. Test scores derived from neuropsychological and positive/negative
psychotic-symptom measures were obtained via an archival dataset and analyzed with
three hypotheses in mind. The first two hypotheses suggested distinct relationships
between positive and negative symptoms of psychosis and domain-specific cognitive
deficits. These hypotheses originated from the assumption that cognitive deficits in
psychosis are specific to certain cognitive domains depending on the type and severity of
the psychotic presentation (Gilbert et al., 2014). The assumption of domain-specific
deficits contrasts with other schools of thought in which globalized cognitive deficits
(i.e., deficits across all cognitive domains) are thought to be implicated in schizophrenia.
Specifically, the first hypothesis suggested negative symptoms of psychosis would
be positively correlated with deficits in executive functioning and processing speed,
meaning individuals who scored high on negative symptoms would have more severe
deficits in complex problem solving and rapidity of processing tasks. Conversely, the
results indicated that individuals who scored high on negative symptoms, scored lower
across all cognitive domains: memory, attention, problem solving, and processing speed.
Thus, the results were inconsistent with the domain-specific cognitive-deficit theory and
instead supported the globalized-deficit approach.
Similarly, the second hypothesis posited that individuals who scored high on
measures of positive symptoms would score lower on measures of memory and attention.
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The results indicated a significant relationship between memory and positive symptoms
only, suggesting that individuals with greater positive symptoms performed poorer on
memory tasks as compared to other cognitive domains. Since attention deficits were not
significantly related to positive symptoms, one can surmise that individuals with
predominant positive symptoms have difficulty encoding and thus later recalling
information, but do not necessarily have difficulty attending to the information in the first
place.
On the whole, individuals with more severe negative symptoms than positive
symptoms experience greater deficits across all cognitive domains, whereas individuals
with more severe positive symptoms experience deficits that are specific to memory. One
theory to explain this notion is that positive symptoms and negative symptoms of
psychosis likely have distinct neurological substrates. Moreover, negative symptoms,
such as apathy, flattened affect, social withdrawal, and avolition, are components that
necessitate and underlie many cognitive processes (Erhart et al., 2006). Thus, without
motivation, attention, and emotional interest, all types of cognitive processes are
hindered.
Positive symptoms, however, require an overproduction of the perceptual system,
whereby attention and problem solving are germane to hypervigilance, paranoia, and
delusions. Recent studies have identified a relationship between working-memory deficits
and delusions, with the idea being that working memory is required for coming to
rational conclusions about everyday experiences (Freeman et al., 2013). Thus, a positive
correlation between positive symptoms of psychosis and memory deficits is conceivable.
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The final hypothesis suggested that subtypes of schizophrenia could be gleaned
from the application of a cluster analysis. The results obtained herein suggest the
existence of two subtypes of schizophrenia. The first subtype, hereafter referred to as the
Deficit subtype, was comprised of participants who scored lower across all cognitive
domains and higher on scores of positive and negative symptoms of psychosis.
Conversely, the second subtype, hereafter referred to as the Nondeficit subtype, was
comprised of individuals who scored higher across all cognitive domains and lower on
positive and negative symptoms. The delineation of these subtypes was clear. Thus,
schizophrenia as a broad diagnostic category is actually comprised of two distinct
phenomena, and possibly two distinct diagnoses entirely.
Moreover, the two subtypes identified in the present study differed significantly
on the following variables of interest: race, employment, education, and history of
antipsychotic medication. Specifically, the Deficit subtype was comprised of more Black
participants than White, had fewer years of education, and had a longer duration since
first prescribed antipsychotic medication. The Nondeficit subtype, conversely, was
comprised of more White than Black participants, had a longer work history, had more
education, and had fewer years since first prescribed antipsychotic medication. One
potential explanation is that socioeconomic factors play a large role in onset and course
of illness in schizophrenia. Specifically, education and work history may serve as
protective factors against an earlier age at onset, as well as against symptom severity and
associated cognitive deficits.
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Implications
Individuals with schizophrenia vary considerably in onset, severity, course, and
duration of their illness (Buchanan & Carpenter, 1994). The need for subtypes to reduce
this variability has been well documented in the literature (Fenton & McGlashan, 1991).
The implications for this study are trifold: (a) Identifying subtypes of schizophrenia may
reduce the widespread heterogeneity inherent in the disorder, and thus perhaps improve
diagnostic clarity; (b) Using a neurocognitively driven approach to conceptualizing the
disorder can elucidate the etiology and pathophysiology of schizophrenia through
identifying brain-behavior relationships, which may have further implications on risk
management and prevention; and (c) diagnostic clarity and specificity can foster accurate
treatment targets, which could consequently improve treatment outcomes.
Subtypes based on attempts at symptomatic differentiation from previous editions
of the Diagnostic and Statistical Manual of Mental Disorders were unsuccessful in
clarifying the etiopathophysiology or heterogeneity in schizophrenia (Braff et al., 2013).
Essentially, the tendency for symptom overlap and transient manifestations of symptoms
detracted from their utility, meaning that symptoms were unreliable markers of subtypes
(Tandon et al., 2013). Nonetheless, the need to identify homogenous groups within
schizophrenia to inform treatment remains evident. The neurocognitive correlates of
schizophrenia are stable and reliable indicators of the disorder (Bora, 2014). Thus, basing
subtypes on neurocognitive, rather than symptomatic, data will likely yield lasting
etiological subtypes.
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Furthermore, this type of phenotypic refinement has been applied successfully in
other complex disorders, such as Parkinson’s disease (Dekker et al., 2003) and
Alzheimer’s disease (Scott et al., 2003), both of which have demonstrated advances in
diagnostic, conceptual, and treatment dimensions as a result (Geisler et al., 2015). The
primary implication of identifying subtypes of schizophrenia based on differential
neurocognitive profiles rests in its ability to explicate distinct etiologic mechanisms.
Research suggests that the etiology and onset of schizophrenia can be caused by a
multitude of factors and that differences at onset might likely account for the
heterogeneity in schizophrenia as a whole (Rajji, Ismail, & Mulsant, 2009). Research has
further suggested that factors at onset, such as age, severity, and type of episode, may be
linked to specific subtypes. For example, individuals with an earlier age at onset are more
likely to have profound memory deficits and experience more positive symptoms than
those who develop schizophrenia later on (Johnstone et al., 1989). Thus, identifying
subtypes in this way may further an understanding of the relationship between the onset
and course of schizophrenia, which may in turn inform prevention strategies and risk
management (Zhang et al., 2015).
Finally, this study has implications on the course and type of treatment in
schizophrenia. Reducing the heterogeneity aids in individualized treatment plans (Gilbert
et al., 2014). Tailoring treatment to the individual is especially important in
schizophrenia, given the extraordinary variability among patients. In addition to
individualized treatment protocols, identifying neuropsychologically based subtypes may
alter the focus of treatment from traditional to computerized approaches. Recently,
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cognitive-based interventions akin to those used in cases of traumatic brain injury and
neurological disorders, such as cognitive remediation now used in schizophrenia, have
surged (Medalia & Saperstein, 2013). Identifying subtypes of schizophrenia based on
differential neurocognitive profiles can inform cognitive-remediation regimens that target
the cognitive deficits that are specific to that subtype. In turn, these individualized
treatment plans will likely engender better treatment outcomes. Specifically, cognitive
deficits in schizophrenia have been highly correlated with functional outcomes (Medalia
& Saperstein, 2013). Thus, this treatment approach will likely have implications on
patients’ quality of life, activities of daily living, and general social and occupational
functioning.
The Deficit and Nondeficit subtype groups outlined in this study can assist in
improving diagnostic accuracy. Specifically, individuals may be diagnosed based
predominantly on their neurocognitive profiles. Neurocognitive profiles with globalized
cognitive deficits would likely fit the Deficit subtype, whereas those scoring low only in
memory would likely belong to the Nondeficit subtype. This categorization would then
aid in the selection of appropriate treatment options. Those belonging to the Nondeficit
subtype would likely benefit from cognitive remediation of memory, in hopes that
improved memory will assist in the cognitive restructuring of delusions and thereby
reduce positive symptoms, whereas the Deficit subtype would likely benefit from a
globalized cognitive-remediation approach. Moreover, education and work history may
serve as protective factors against symptom severity and associated cognitive deficits.
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Therefore, prevention strategies could utilize this subtyping method for early intervention
via the implementation of education and employment programs for at-risk individuals.
Limitations
A potential limitation of this study is the exclusion of psychotic-spectrum
disorders that are not schizophrenia. Some researchers conceptualize schizophrenia as a
part of a continuum along the psychotic disorders spectrum and believe that its current
classification is erroneous, limited, and flawed. Through excluding other psychoticspectrum disorders, one risks subscribing to the confines of a diagnostic category that
might limit or impede a more thorough understanding of psychosis in general. Therefore,
a possible limitation of this study is that the results are reflective of an already flawed
diagnostic system.
Other potential limitations may stem from the archival dataset used in the current
study. Namely, the aims of the parent study required a sampling of typical and atypical
antipsychotics. It is widely acknowledged that typical, or first-generation, antipsychotics
often impair cognitive functioning further in schizophrenia (Han et al., 2015). By not
controlling for these variables, some of the neuropsychological performances across
participants might have been unduly influenced by medication effects. Similarly,
participants with incomplete data were deleted from the present study; therefore, whether
the missing data was the result of random or systematic occurrence cannot be determined.
Therefore, another limitation is possibly unaccounted-for differences between the sample
and population that cannot be ascertained in the current analysis.
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Furthermore, the present study examined the associations between positive and
negative symptoms of psychosis as they relate to cognitive deficits. Some researchers
argue that this binary conceptualization is, in fact, a false dichotomy and that psychosis is
actually composed of a variety of symptom domains (David & Appleby, 1992). Similarly,
neurocognitive deficits included in this study were based on cognitive domains most
commonly implicated in schizophrenia. The results must be interpreted with the
limitation that other cognitive domains, such as social cognition, were not included.
Likewise, despite growing research in favor of a domain-specific deficit approach
to cognition in schizophrenia, a body of literature favors the generalized-deficit theory.
The generalized-deficit theory states that individuals with schizophrenia have cognitive
deficits across all domains, such as memory and executive functioning, and that
differential impairments do not exist (Dickinson et al., 2008). A major limitation of this
study, then, is that it is based on the assumption that individuals with schizophrenia are
differentially impaired across cognitive domains and that these differences are associated
with specific symptom presentations as well. The present study failed to align with the
domain-specific theory, but rather more so supported the globalized-deficit approach.
Moreover, one should note that the correlations presented between cognitive deficits and
psychotic symptoms are likely attenuated by the limited reliability of the measures. What
has been presented herein are the raw correlations.
Likewise, this study is limited by not controlling for differences in premorbid
adjustment and age of onset. Studies have consistently indicated that premorbid
adjustment and age of onset can have a profound impact on the nature, course, and
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severity of both cognitive deficits and symptom presentations in schizophrenia (Rund et
al., 2004). The findings often indicate that earlier age of onset yields a poorer prognosis
in regard to cognitive deficits and that better premorbid adjustment can predict better
cognitive performances at later points in time (Fuller et al., 2002). Thus, not controlling
for these variables suggests the results may be a reflection of differences that predate the
disorder itself.
Future Research
Future research should include all psychotic-spectrum disorders to determine
whether greater clusters of subtypes are more representative of psychosis than are the
predetermined diagnostic categories in the DSM-5. This delineation might help to fully
restructure the current criteria from which diagnoses are made. Furthermore, future
research should include a measure of social cognition, as it is another cognitive domain
implicated in schizophrenia that was not examined in the present study. Social cognition
is an emerging dimension of schizophrenia that is linked to functional outcomes (Fett,
Viechtbauer, Penn, van Os, & Krabbendam, 2011). Therefore, identifying patterns of
social cognition as they relate to other cognitive deficits and psychotic symptoms may
elucidate another subtype that has yet to be explored, and one that may have implications
on functional outcomes for individuals with schizophrenia. Additionally, future studies
should work to control for variations that predate disease onset and to attempt to replicate
the current findings.
Finally, future research should look to converge the literature on structural
magnetic resonance imaging (MRI) in schizophrenia with the literature on subtypes.

IDENTIFYING SUBTYPES OF SCHIZOPHRENIA

67

Previous studies have attempted to demonstrate structural differences in the brain among
previously established subtypes of schizophrenia (Gur et al., 1994; Turetsky et al., 1995;
Sallet et al., 2003). Future research should look to validate the subtypes outlined in this
study via structural MRI differentiation. Doing so may explicate the pathophysiology and
etiology of schizophrenia, with subsequent implications on intervention strategies as well.
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